Sentry Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-20,687
Closed -$3.66M 506
2020
Q1
$3.66M Buy
20,687
+2,951
+17% +$556K 0.27% 89
2019
Q4
$3.39M Hold
17,736
0.2% 130
2019
Q3
$2.98M Hold
17,736
0.2% 135
2019
Q2
$2.97M Buy
17,736
+1,333
+8% +$185K 0.2% 129
2019
Q1
$2.4M Sell
16,403
-4,522
-22% -$656K 0.17% 153
2018
Q4
$2.8M Sell
20,925
-524
-2% -$85.9K 0.2% 130
2018
Q3
$4.09M Sell
21,449
-640
-3% -$118K 0.25% 105
2018
Q2
$3.68M Sell
22,089
-2,450
-10% -$393K 0.24% 109
2018
Q1
$4.13M Sell
24,539
-2,322
-9% -$389K 0.25% 105
2017
Q4
$4.39M Sell
26,861
-10
-0% -$1.79K 0.24% 112
2017
Q3
$5.51M Sell
26,871
-18
-0.1% -$4.19K 0.21% 83
2017
Q2
$6.54M Buy
26,889
+265
+1% +$62.3K 0.26% 66
2017
Q1
$6.36M Sell
26,624
-4,374
-14% -$1.02M 0.26% 63
2016
Q4
$6.51M Sell
30,998
-634
-2% -$131K 0.27% 61
2016
Q3
$7.29M Buy
31,632
+724
+2% +$177K 0.32% 54
2016
Q2
$7.14M Hold
30,908
0.31% 53
2016
Q1
$8.28M Buy
30,908
+320
+1% +$91.6K 0.37% 48
2015
Q4
$9.56M Buy
30,588
+619
+2% +$184K 0.44% 41
2015
Q3
$8.15M Buy
29,969
+662
+2% +$203K 0.4% 43
2015
Q2
$8.89M Buy
29,307
+2,491
+9% +$743K 0.42% 45
2015
Q1
$7.98M Buy
26,816
+14,880
+125% +$4.24M 0.38% 51
2014
Q4
$3.07M Hold
11,936
0.15% 119
2014
Q3
$2.88M Buy
11,936
+2,805
+31% +$628K 0.15% 109
2014
Q2
$2.04M Sell
9,131
-669
-7% -$139K 0.11% 163
2014
Q1
$2.02M Hold
9,800
0.11% 152
2013
Q4
$1.65M Sell
9,800
-2,800
-22% -$438K 0.09% 172
2013
Q3
$1.81M Buy
12,600
+1,800
+17% +$240K 0.11% 150
2013
Q2
$1.36M Buy
+10,800
New +$1.22M 0.08% 132

Other funds holding AGN

Sentry Investment Management's AGN Position: Q2 2020 in Review

Sentry Investment Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 20,687 shares — an estimated $3.66M sold.

Sentry Investment Management first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $9.56M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Sentry Investment Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Sentry Investment Management sold 20,687 Allergan plc shares in Q2 2020, an estimated $3.66M.
  • Sentry Investment Management first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Sentry Investment Management's Allergan plc position peaked at $9.56M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Sentry Investment Management's 13F filing for Q2 2020, filed 7 Aug 2020.